Leonard Saltz
机构: Professor of Medicine, Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center
每年引用次数
引用次数
引用: 87,979
H-指数: 150
I10-指数 : 438
出版物: 863
Adjuvant Therapy for Colon Cancer
Leonard B. Saltz
Surgical Oncology Clinics of North America 19 ( 4) 819 -827
19
2010
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas.
Sandy Liu , Mithat Gӧnen , Zsofia K. Stadler , Martin R. Weiser
Modern Pathology 32 ( 1) 110 -121
10
2019
Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature
Yevgeniy Karamurzin , Zhaoshi Zeng , Zsofia K. Stadler , Liying Zhang
Human Pathology 43 ( 10) 1677 -1687
68
2012
Phase I Study of Weekly Cisplatin, Bolus Fluorouracil and Escalating Doses of Irinotecan in Advanced Solid Tumors
Geoffrey Y. Ku , Eileen M. O'Reilly , Leonard B. Saltz , Deborah Schrag
Cancer Investigation 27 ( 4) 402 -406
1
2009
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
J. Joshua Smith , Paul Strombom , Oliver S. Chow , Campbell S. Roxburgh
JAMA Oncology 5 ( 4) 185896
323
2019
The Cost and Value of Anti–Epidermal Growth Factor Receptor Therapies: Let's Not Be Rash
Leonard B. Saltz
JAMA Oncology 1 ( 2) 141 -142
3
2015
Perspectives on Cost and Value in Cancer Care
Leonard B. Saltz
JAMA Oncology 2 ( 1) 19 -21
34
2016
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Andrea Cercek , Campbell S.D. Roxburgh , Paul Strombom , J. Joshua Smith
JAMA Oncology 4 ( 6)
379
2018
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
Erin L. Van Blarigan , Charles S. Fuchs , Donna Niedzwiecki , Sui Zhang
JAMA Oncology 4 ( 6) 783 -790
59
2018
Metabolic Signatures Associated with a NAD Synthesis Inhibitor–Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy
Manickam Muruganandham , Alan A. Alfieri , Cornelia Matei , Yuchun Chen
Clinical Cancer Research 11 ( 9) 3503 -3513
85
2005
A rectal cancer organoid platform to study individual responses to chemoradiation.
Karuna Ganesh , Chao Wu , Kevin P. O’Rourke , Bryan C. Szeglin
Nature Medicine 25 ( 10) 1607 -1614
266
2019
Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer
Jeffrey A. Meyerhardt , Donna Niedzwiecki , Donna Hollis , Leonard B. Saltz
JAMA 298 ( 7) 754 -764
540
2007
Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
Robert S. Warren , Chloe E. Atreya , Donna Niedzwiecki , Vivian K. Weinberg
Clinical Cancer Research 19 ( 20) 5777 -5787
27
2013
Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Shuji Ogino , Kaori Shima , Jeffrey A. Meyerhardt , Nadine J. McCleary
Clinical Cancer Research 18 ( 3) 890 -900
222
2012
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.
Ghassan K. Abou-Alfa , Marinela Capanu , Eileen M. O’Reilly , Jennifer Ma
Journal of Hepatology 60 ( 2) 319 -324
61
2014
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Monica M. Bertagnolli , Robert S. Warren , Donna Niedzwiecki , Elke Mueller
Clinical Cancer Research 15 ( 6) 2116 -2122
14
2009
Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
Leonard B. Saltz , Donna Niedzwiecki , Donna Hollis , Richard M. Goldberg
Journal of Clinical Oncology 25 ( 23) 3456 -3461
364
2007
Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study
Heinz-Josef Lenz , Hedy L. Kindler , Howard S. Hochster , Scott Wadler
Journal of Clinical Oncology 25 ( 29) 4557 -4561
358
2007
Phase II Trial of Sunitinib in Patients With Metastatic Colorectal Cancer After Failure of Standard Therapy
Leonard B. Saltz , Lee S. Rosen , John L. Marshall , Robert J. Belt
Journal of Clinical Oncology 25 ( 30) 4793 -4799
133
2007
Individualized Prediction of Colon Cancer Recurrence Using a Nomogram
Martin R. Weiser , Ron G. Landmann , Michael W. Kattan , Mithat Gonen
Journal of Clinical Oncology 26 ( 3) 380 -385
274
2008